However, if you have been at maximum dose for 12 or more weeks without adequate response, or if side effects prevent further dose increases, switching to tirzepatide is a reasonable next step
The more cautious interpretation is that patients who receive GLP-1 receptor agonists may differ in important but incompletely measured ways from those treated with insulin or metformin, including overall health, treatment access, healthcare follow-up, or cardiometabolic care intensity
GLP-1 medications are protein-based biologics susceptible to degradation from temperature extremes, requiring refrigeration between 2C and 8C before opening
It could support our bodies natural defense mechanisms, boosting our overall health
Answer questions about your health history, current weight, and goals
Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis